Arcellx, Inc. (DELISTED) (ACLX:DL)
115.07
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Arcellx Shareholders Equity (Quarterly) : 402.35M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.70B |
| Eli Lilly & Co. | 31.20B |
| Merck & Co., Inc. | 45.88B |
| Bristol Myers Squibb Co. | 20.07B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.99M |
| Total Liabilities (Quarterly) | 201.64M |
| Debt to Equity Ratio | 0.129 |
| Current Ratio | 4.436 |
| Net Debt Paydown Yield | 0.07% |